4DMedical’s lightning fast $83m raise adds fuel to valuation debate
The medical imaging company has experienced a run for the ages, with the stock up 2,000% in the ASX in less than a year. Not everyone is convinced it can continue.
4DMedical founder and CEO Andreas Fouras freely admits that this time a week ago he wasn’t thinking about raising fresh capital.
But that’s exactly what happened on Friday, when the high-flying medtech announced it had banked $83 million via a private placement to undisclosed institutions.
“I can absolutely tell you at the start of the week, it wasn’t on the cards,” Fouras told Capital Brief.
“Honestly, the investors came to us and to [lead manager and bookrunner] Bell Potter in the last few days. There really has been no groundwork, no work to do this. But nevertheless, it represented compelling value, and we were able to make that decision and move quickly.”